Page last updated: 2024-12-08

o-phosphohomoserine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O-phosphohomoserine: RN given refers to L-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151187
CHEBI ID15961
SCHEMBL ID60701
MeSH IDM0057092

Synonyms (21)

Synonym
4210-66-6
(2s)-2-amino-4-(phosphonooxy)butanoic acid
l-homoserine, dihydrogen phosphate (ester)
homoserine phosphate
CHEBI:15961
o-phosphohomoserine
O-PHOSPHO-L-HOMOSERINE ,
C01102
(2s)-2-amino-4-phosphonooxybutanoic acid
o-phosphonohomoserine
SCHEMBL60701
AKOS028109798
o-phosphono-l-homoserine
o-phospho-homoserine
2-amino-4-hydroxy-butyric acid phosphate
l-2-amino-4-hydroxy-butyric acid dihydrogen phosphate (ester)
Q27098324
(s)-2-amino-4-(phosphonooxy)butanoic acid
DTXSID60962276
(s)-2-amino-4-(phosphonooxy)butanoicacid
EN300-25687692
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
O-phosphorylhomoserineAn O-phosphoamino acid in which the amino acid specified is homoserine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (10)

PathwayProteinsCompounds
Threonine Biosynthesis1123
Secondary Metabolites: Threonine Biosynthesis from Aspartate715
Threonine Metabolism619
methionine biosynthesis020
superpathway of lysine, threonine and methionine biosynthesis II032
isoleucine biosynthesis I024
superpathway of lysine, threonine and methionine biosynthesis I038
threonine biosynthesis016
methionine biosynthesis II018
Threonine biosynthesis07
Sulfate assimilation and copper detoxification020
Methionine biosynthesis II017
Threonine biosynthesis from homoserine07

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (15.79)18.7374
1990's8 (42.11)18.2507
2000's5 (26.32)29.6817
2010's3 (15.79)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.62 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]